matrix in governing the spectral properties of the DsRed
chromophore, we have synthesized 4-hydroxybenzylidene-
1-methyl-2-propenyl-imidazolinone (1, HBMPI) and 4-hy-
droxybenzylidene-1-methyl-2-penta-1,3-dien-1-yl-imidazoli-
none (2, HBMPDI) (Figure 1) and performed an initial
characterization using absorption, fluorescence, and Raman
spectroscopies.
Scheme 2. Synthesis of HBMPDI 2
Due to the susceptibility of acylimines to nucleophilic
attack,7,8 we have initially focused on DsRed model com-
pounds containing olefinic substituents on the imidazolinone
ring. Two such compounds (1 and 2) were prepared via
Erlenmeyer azlactone synthesis as shown in Schemes 1 and
2, respectively.9,10
Scheme 1. Synthesis of HBMPI 1
20% overall yield. 4-Hydroxybenzylidene-1,2-dimethyl-
imidazolinone (HBDI, Figure 1) was also isolated in high
yield from the synthesis of 1. Similarly, HBMPDI 2 was
synthesized using the same strategy with 2,4-hexadienoic acid
as the initial acylating group. However, the 2-methyl-
substituted byproduct, observed in the synthesis of 1, was
not formed, presumably due to steric hindrance in the acetyl
exchange reaction. Compound 2 was obtained in 25% overall
yield. The absorption spectra of 1 and 2 are shown in Figures
2 and 3, respectively.
For compound 1, glycine was first acylated with crotonic
acid under alkaline conditions.11 Reaction of N-crotonylg-
lycine with 4-hydroxybenzaldehyde and anhydrous sodium
acetate in acetic anhydride provided the corresponding
intermediate azlactone 3 together with a byproduct having a
methyl group in place of the crotonyl group at the imida-
zolinone C2 position. The formation of the byproduct is
postulated to result from replacement of the N-crotonyl group
with an acetyl group derived from the solvent.
1H NMR analysis indicated that the product from the first
step of the synthesis contained more than 60% of the desired
azlactone, and this was used for the next step of the reaction
without purification. Subsequent treatment of 3 with me-
thylamine in the presence of K2CO3 afforded HBMPI 1 in
(5) Baird, G. S.; Zacharias, D. A.; Tsien, R. Y. Proc. Natl. Acad. Sci.
U.S.A 2000, 97, 11984-11989.
Figure 2. Absorption spectra for the cationic ([[[, 1 M HCl),
neutral (s[s[, 20 mM sodium acetate pH 5.5), and anionic (s
s, 1 M KOH) forms of HBMPI 1.
(6) Gross, L. A.; Baird, G. S.; Hoffman, R. C.; Baldridge, K. K.; Tsien,
R. Y. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 11990-11995.
(7) Kupfer, R.; Meier, S.; Wurthwein, E. U. Synthesis 1984, 688-690.
(8) Malassa, I.; Matthies, D. Chemiker-Zeitung 1987, 111, 253-261.
(9) Buck, J. S.; Ide, W. S. Organic Syntheses; Wiley: New York, 1943;
Collect. Vol. II, p 55-56.
(10) Kojima, S.; Ohkawa, H.; Hirano, T.; Maki, S.; Niwa, H.; Ohashi,
M.; Inouye, S.; Tsuji, F. I. Tetrahedron Lett. 1998, 39, 5239-5242.
(11) Sheehan, J. C.; Duggins, W. E. J. Am. Chem. Soc. 1950, 72, 2475-
2477.
Due to the extension of the conjugated system compared
to HBDI (λmax ) 368 and 425 nm for neutral and anionic
forms, respectively), the absorption maxima of the neutral
1524
Org. Lett., Vol. 4, No. 9, 2002